PEPG: Total Utang marang Modal PepGen Corp

Logo perusahaan publik PepGen Inc. (PEPG)

The prospects for the biotechnology sector rely on the creation of effective means for regenerating muscle functions in hereditary pathologies. This price chart for PepGen Inc. (PEPG) demonstrates a debt-to-equity ratio of 0.12. Development is funded through partnerships with industry behemoths, as the company lacks the internal capital for mergers. Unique RNA therapies and patent protection for drug delivery methods ensure stable demand.

PEPG - Total Utang marang Modal PepGen Corp ing rentang 28.04.2023 - 29.10.2026

Rincian metrik lan analitis perusahaan PepGen (PEPG)

- rega lan prakiraan konsensus rega:
Bagan rega PepGen Inc|PEPG - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Kapitalisasi pasar PepGen|PEPG - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Akuntansi saben Saham PepGen|PEPG - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku pepgen.com|PEPG - Nilai Agregat Aset
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas PepGen Inc.|PEPG - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas PepGen Inc|PEPG - Gunggung tanggungan utang perusahaan|Utang-utang marang kapitalisasi buku PepGen|PEPG - Utang jangka dawa|Utang jangka cendhak perusahaan PepGen
Ringkesan analitik perusahaan:PepGen Inc., PEPG
Barang utama PepGen Inc

Developing a unique EDO platform for muscular dystrophy therapy, PepGen Inc. requires significant R&D investments, which is reflected in the current total debt-to-equity ratio of 0.12. This ratio compares total liabilities to equity, measuring financial leverage and the biotech firm's reliance on borrowed capital to assess business resilience against default risks.

Pesaing PepGen Inc.

Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal xenon-pharma.com XENE|VKTX - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Utang marang Ekuitas|Utang marang Modal Denali Corp (DNLI)|Utang marang Ekuitas Harmony Biosciences|biohavenpharma.com - Utang Agregat marang Ekuitas|Total Utang marang Modal AMLX|TRVI - Utang marang Modal|Utang marang Ekuitas Praxis Medicines PRAX|AVXL (Anavex Life Sciences Corp) - Utang Agregat marang Ekuitas|CeriBell, Inc. - Total Utang marang Modal|Rasio Utang marang Modal Prothena Corporation PLC (PRTA)|ALEC: Total Utang marang Modal|Utang marang Modal Annexon Biosciences (ANNX)|Utang marang Ekuitas Omeros Corp|Rasio Utang marang Ekuitas NGNE (Neurogene Therapeutics)|Rasio Total Utang marang Ekuitas ACIU (AC Immune)|VYGR (voyagertherapeutics.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal NMRA (Neumora Therapeutics, Inc.)|Koefisien Total Utang marang Modal Scilex Holding (SCLX)|TVGN - Utang marang Ekuitas|ACOG (Alpha Cognition) - Rasio Utang marang Ekuitas|CGTX: Total Utang marang Modal|Rasio Total Utang marang Ekuitas inhibikase.com|Rasio Total Utang marang Ekuitas SAVA|Assertio Therapeutics (ASRT) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Coya Therapeutics, Inc. (COYA)|VTGN: Utang Agregat marang Ekuitas|Total Utang marang Modal OVID (Ovid Therapeutics)|acumenpharm.com (ABOS) - Utang marang Modal|CRVO - Utang marang Ekuitas|Utang Agregat marang Ekuitas ATHE|CLNN: Total Utang marang Modal|Rasio Utang marang Modal Jupiter Neurosciences, Inc. JUNS|Utang marang Ekuitas Relmada Therapeutics|Rasio Utang marang Ekuitas ANVS (annovisbio.com)|Total Utang marang Modal GRCE|AIFF - Utang marang Modal|Klotho Neurosciences - Rasio Total Utang marang Ekuitas|Total Utang marang Modal NeuroSense Therapeutics Ltd NRSN|RVPH - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi MTVA (MetaVia Inc)|NeurAxis (NRXS) - Utang marang Ekuitas|Utang marang Modal Helius Medical Technologies (HSDT)|Utang marang Ekuitas Passage Bio Inc.|Neuphoria - Utang Agregat marang Ekuitas|Total Utang marang Modal NERV|ATHA - Utang marang Modal|Utang marang Ekuitas Addex Therapeutics Ltd ADXN|ALZN (Alzamend Neuro Inc.) - Utang Agregat marang Ekuitas|Cyclerion - Total Utang marang Modal|Rasio Utang marang Modal Protagenic Therapeutics (PTIX)|KTTA: Total Utang marang Modal|Utang marang Modal Cortigent (CRGT)|Utang marang Ekuitas Avenue Therapeutics, Inc.|Rasio Utang marang Ekuitas BCLI (Brainstorm Cell Therapeutics Inc.)|Rasio Total Utang marang Ekuitas CARA (Cara Therapeutics, Inc)|CHRO (Chromocell) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ELYM (Eliem Therapeutics Inc.)|Koefisien Total Utang marang Modal Intra-Cellular Therapies Inc. (ITCI)|LBPH - Utang marang Ekuitas|MRNS (Marinus Pharmaceuticals Inc) - Rasio Utang marang Ekuitas|NKGN: Total Utang marang Modal|Rasio Total Utang marang Ekuitas NeuroBo Pharma|Rasio Total Utang marang Ekuitas SAGE|synaptogen.com (SNPX) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Trevena (TRVN)|VIGL: Utang Agregat marang Ekuitas|Total Utang marang Modal WENA (Anew Medical)|Cerevel Corp (CERE) - Utang marang Modal